It was discovered that the CDKN2A gene's mutation rate in lung cancer tissues was greater than that in nearby tissues, and that patients with CDKN2A mutations had higher recurrence rates than patients with wild-type CDKN2A. The gene discussed is CDKN2A; the disease is lung carcinoma.